Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

United Therapeutics EBITDA Margin 2010-2025 | UTHR

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for United Therapeutics (UTHR) over the last 10 years. The current EBITDA margin for United Therapeutics as of March 31, 2025 is .
  
United Therapeutics EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $2.99B $1.48B 49.47%
2024-12-31 $2.88B $1.45B 50.35%
2024-09-30 $2.76B $1.35B 48.82%
2024-06-30 $2.62B $1.32B 50.59%
2024-03-31 $2.50B $1.31B 52.46%
2023-12-31 $2.33B $1.24B 53.18%
2023-09-30 $2.21B $1.15B 52.29%
2023-06-30 $2.11B $1.14B 53.98%
2023-03-31 $1.98B $1.03B 51.92%
2022-12-31 $1.94B $1.03B 53.28%
2022-09-30 $1.86B $1.03B 55.11%
2022-06-30 $1.79B $0.94B 52.49%
2022-03-31 $1.77B $0.96B 54.21%
2021-12-31 $1.69B $0.61B 35.94%
2021-09-30 $1.66B $0.50B 30.31%
2021-06-30 $1.59B $0.49B 31.05%
2021-03-31 $1.51B $0.41B 27.36%
2020-12-31 $1.48B $0.64B 43.36%
2020-09-30 $1.41B $0.64B 45.49%
2020-06-30 $1.43B $0.60B 42.21%
2020-03-31 $1.44B $0.68B 47.33%
2019-12-31 $1.45B $-0.14B -9.79%
2019-09-30 $1.52B $-0.08B -5.00%
2019-06-30 $1.53B $-0.11B -7.38%
2019-03-31 $1.60B $-0.12B -7.43%
2018-12-31 $1.63B $0.84B 51.72%
2018-09-30 $1.71B $0.85B 49.47%
2018-06-30 $1.75B $1.02B 58.45%
2018-03-31 $1.75B $0.89B 51.00%
2017-12-31 $1.73B $0.85B 49.04%
2017-09-30 $1.67B $0.88B 52.78%
2017-06-30 $1.63B $0.80B 48.81%
2017-03-31 $1.60B $0.99B 62.09%
2016-12-31 $1.60B $1.09B 68.36%
2016-09-30 $1.60B $1.07B 67.34%
2016-06-30 $1.57B $1.22B 77.30%
2016-03-31 $1.51B $1.11B 73.46%
2015-12-31 $1.47B $0.73B 49.93%
2015-09-30 $1.41B $0.74B 52.74%
2015-06-30 $1.35B $0.33B 24.72%
2015-03-31 $1.33B $0.34B 25.55%
2014-12-31 $1.29B $0.57B 44.41%
2014-09-30 $1.23B $0.38B 31.11%
2014-06-30 $1.20B $0.52B 43.14%
2014-03-31 $1.16B $0.46B 39.97%
2013-12-31 $1.12B $0.34B 30.53%
2013-09-30 $1.07B $0.50B 46.27%
2013-06-30 $1.01B $0.47B 46.54%
2013-03-31 $0.96B $0.45B 47.34%
2012-12-31 $0.92B $0.46B 50.66%
2012-09-30 $0.87B $0.40B 46.14%
2012-06-30 $0.83B $0.42B 51.03%
2012-03-31 $0.79B $0.43B 54.90%
2011-12-31 $0.74B $0.36B 48.66%
2011-09-30 $0.71B $0.31B 43.94%
2011-06-30 $0.68B $0.27B 39.88%
2011-03-31 $0.63B $0.22B 34.24%
2010-12-31 $0.59B $0.21B 35.02%
2010-09-30 $0.53B $0.19B 35.78%
2010-06-30 $0.46B $0.14B 29.85%
2010-03-31 $0.41B $0.07B 16.91%
2009-12-31 $0.36B $0.06B 15.32%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $14.382B $2.877B
United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by Eli Lilly as Cialis for erectile dysfunction) tablets.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.830B 32.20
Zoetis (ZTS) United States $75.075B 28.01
Daiichi Sankyo, - (DSNKY) Japan $50.952B 25.92
Takeda Pharmaceutical (TAK) Japan $47.824B 9.51
Sandoz Group AG (SDZNY) Switzerland $22.282B 0.00
Merck (MKKGY) Germany $17.034B 12.48
Shionogi (SGIOY) Japan $14.036B 0.00
Summit Therapeutics (SMMT) United States $13.528B 0.00
Neurocrine Biosciences (NBIX) United States $12.175B 41.70
IPSEN (IPSEY) France $9.924B 0.00
Orion OYJ (ORINY) Finland $9.462B 25.59
Corcept Therapeutics (CORT) United States $8.225B 66.86
Stevanato Group S.p.A (STVN) Italy $6.726B 41.13
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.112B 0.00
Grifols, S.A (GRFS) Spain $5.714B 0.00
Ionis Pharmaceuticals (IONS) United States $5.333B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.696B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.045B 10.67
Crinetics Pharmaceuticals (CRNX) United States $2.857B 0.00
Hypermarcas (HYPMY) Brazil $2.812B 18.50
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.294B 12.41
BioCryst Pharmaceuticals (BCRX) United States $2.249B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.033B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.804B 0.00
Indivior (INDV) United States $1.773B 7.52
Recursion Pharmaceuticals (RXRX) United States $1.699B 0.00
ARS Pharmaceuticals (SPRY) United States $1.417B 0.00
Evotec AG (EVO) Germany $1.410B 0.00
Dyne Therapeutics (DYN) United States $1.359B 0.00
Guardian Pharmacy Services (GRDN) United States $1.340B 0.00
Ocular Therapeutix (OCUL) United States $1.276B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.059B 21.19
Harrow (HROW) United States $1.031B 0.00
Collegium Pharmaceutical (COLL) United States $0.936B 5.05
Avadel Pharmaceuticals (AVDL) Ireland $0.881B 0.00
Ardelyx (ARDX) United States $0.878B 0.00
Enliven Therapeutics (ELVN) United States $0.872B 0.00
Akebia Therapeutics (AKBA) United States $0.796B 0.00
Xeris Biopharma Holdings (XERS) United States $0.773B 0.00
Cronos Group (CRON) Canada $0.763B 0.00
AleAnna (ANNA) United States $0.624B 0.00
KalVista Pharmaceuticals (KALV) United States $0.587B 0.00
Elite Pharmaceuticals (ELTP) United States $0.577B 0.00
Xencor (XNCR) United States $0.569B 0.00
USANA Health Sciences (USNA) United States $0.556B 12.09
Regulus Therapeutics (RGLS) United States $0.549B 0.00
Bioventus (BVS) United States $0.532B 13.50
Relay Therapeutics (RLAY) United States $0.514B 0.00
Zevra Therapeutics (ZVRA) United States $0.468B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.459B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.458B 0.00
Altimmune (ALT) United States $0.440B 0.00
Tourmaline Bio (TRML) United States $0.428B 0.00
Siga Technologies (SIGA) United States $0.427B 8.93
Oruka Therapeutics (ORKA) United States $0.410B 0.00
Verve Therapeutics (VERV) United States $0.397B 0.00
Savara (SVRA) United States $0.394B 0.00
Organogenesis (ORGO) United States $0.348B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.343B 9.28
Tonix Pharmaceuticals Holding (TNXP) United States $0.291B 0.00
Heron Therapeutics (HRTX) United States $0.287B 0.00
Nature's Sunshine Products (NATR) United States $0.284B 26.20
Aquestive Therapeutics (AQST) United States $0.269B 0.00
MediWound (MDWD) Israel $0.237B 0.00
ProKidney (PROK) United States $0.212B 0.00
Nanobiotix S.A (NBTX) France $0.193B 0.00
Journey Medical (DERM) United States $0.188B 0.00
Esperion Therapeutics (ESPR) United States $0.168B 0.00
4D Molecular Therapeutics (FDMT) United States $0.168B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Profound Medical (PROF) Canada $0.158B 0.00
Aclaris Therapeutics (ACRS) United States $0.158B 0.00
OmniAb (OABI) United States $0.155B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Avita Medical (RCEL) United States $0.149B 0.00
Wellgistics Health (WGRX) United States $0.144B 0.00
Larimar Therapeutics (LRMR) United States $0.144B 0.00
Liminatus Pharma (LIMN) $0.141B 0.00
Nektar Therapeutics (NKTR) United States $0.135B 0.00
Lyell Immunopharma (LYEL) United States $0.129B 0.00
Aldeyra Therapeutics (ALDX) United States $0.129B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.127B 0.00
Achieve Life Sciences (ACHV) Canada $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Protara Therapeutics (TARA) United States $0.117B 0.00
Korro Bio (KRRO) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
VAXART, INC (VXRT) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Cassava Sciences (SAVA) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.097B 0.00
Fractyl Health (GUTS) United States $0.093B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Inotiv (NOTV) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.081B 13.34
Pyxis Oncology (PYXS) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 55.11
Surrozen (SRZN) United States $0.073B 0.00
Nutriband (NTRB) United States $0.073B 0.00
Unicycive Therapeutics (UNCY) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.065B 0.00
Assertio Holdings (ASRT) United States $0.064B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Telomir Pharmaceuticals (TELO) United States $0.058B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Context Therapeutics (CNTX) United States $0.052B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.046B 0.00
Century Therapeutics (IPSC) United States $0.046B 0.00
NRx Pharmaceuticals (NRXP) United States $0.046B 0.00
PMV Pharmaceuticals (PMVP) United States $0.046B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Karyopharm Therapeutics (KPTI) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Acrivon Therapeutics (ACRV) United States $0.033B 0.00
FibroGen (FGEN) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.026B 0.00
Relmada Therapeutics (RLMD) United States $0.025B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Tempest Therapeutics (TPST) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
BioVie (BIVI) United States $0.019B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Ainos (AIMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
GlycoMimetics (GLYC) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Scienture Holdings (SCNX) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.011B 1.88
Talphera (TLPH) United States $0.010B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
SHINECO (SISI) China $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00